The short version for procurement
When a lot certificate reports ≥99% HPLC purity, the issuing lab is saying that under the stated chromatographic method, the main peak accounts for at least 99% of the integrated signal attributed to analytes in that run. It is a quality metric for that lot — not a clinical grade, not a potency claim for any organism, and not a guarantee that every downstream assay will behave the same way your last lot did.
Nextday Peptides does not advertise a catalog-wide HPLC percentage. Lot documentation / COA is available; review the applicable certificate for reported test results and methodology. If a product page and a lot file disagree, the lot file wins until someone explains the discrepancy.
This article is written for people who buy and receive research peptides for bench use: PIs, lab managers, purchasing officers, and technicians who have to defend a SKU choice when a control fails. It explains what the percentage is doing, what it cannot see, and how to talk about purity without overselling it to colleagues who only skim the product card.
If you only remember one sentence for a lab meeting: HPLC purity is a method-bound area-percent claim for a lot, useful for research procurement, silent on identity unless identity testing is listed beside it, and unrelated to any non-laboratory use narrative.
What HPLC is actually measuring
High-performance liquid chromatography separates sample components as they move through a column under a controlled solvent program. A detector — often UV at a chosen wavelength for peptides — records peaks over time. Integration software assigns area to each peak and reports the main analyte as a percentage of the total integrated area that the method treats as relevant. The headline number is only meaningful relative to that method: column chemistry, particle size, gradient shape, flow rate, detection wavelength, sample solvent, injection volume, and the lab's integration rules.
Two labs can both report “HPLC purity” and still not be describing identical experimental conditions. That is normal analytical chemistry, not a vendor trick. What matters for buyers is whether the method is stated clearly enough that you can compare lots over time and whether identity work sits beside the purity line so you are not mistaking a clean peak for a correctly named peak.
Compounds that do not absorb at the monitored wavelength, or that co-elute with the main peak, can sit outside what the purity percentage “sees.” Early-eluting salts, late-eluting aggregates, and species that hide under the main peak are classic blind spots. That is why stronger lot packages pair HPLC with mass spectrometry or another orthogonal identity check rather than treating area percent as a complete chemical biography.
Sample preparation upstream of the column matters too. Incomplete dissolution, filtration choices, and diluent mismatch can distort peak profiles before the gradient even starts. When troubleshooting an unexpected purity string, ask whether the COA notes preparation conditions — and whether your own in-house confirmation used a comparable approach.
Purity is not identity
A 99% peak still needs a name. Identity testing asks whether that peak is the intended sequence or small molecule. Mass spectrometry, amino-acid analysis, or comparison to a reference retention time answers a different question than peak-area purity. Confusing the two is how teams order the wrong cousin sequence and only notice when the molecular ion refuses to match the protocol.
When you file paperwork for a study, record both: the HPLC result and the identity method listed for that lot. Our guide on how to read a research peptide COA walks through matching those fields to the vial label without turning this article into a full COA tutorial. Keep the split simple in lab meetings: purity answers “how clean under this method,” identity answers “is it the molecule we think it is.”
Catalog names make the confusion worse when synonyms collide. A storefront title for BPC-157 or TB-500 is a convenience label; the sequence, salt notes, and lot identity section are what belong in the experimental record. If two vendors use the same nickname for slightly different fragments, HPLC purity alone will not rescue the mix-up.
Teach purchasing staff to ask for identity confirmation language in quotes when protocols are sequence-critical. A purity promise without an identity method is an incomplete answer for those assays, even when the percentage looks excellent on a slide.
Method limits worth saying out loud
UV-based HPLC purity is a relative measurement within the detector's response window. It is not a universal mole fraction of every atom in the vial. Residual solvents, counterions, and water content may be handled by other tests — or may not appear on a lean research COA at all. Labs that need absolute assay by a second technique should specify that in the purchasing brief rather than assuming area percent equals gravimetric content.
Gradient and column choices also change how deletion sequences, incompletely deprotected species, and closely related isomers resolve. A method tuned for a short peptide may under-resolve impurities on a longer chain. When your protocol is sensitive to a known process impurity, ask whether the reported method is expected to separate that species instead of treating a high area-percent as magic armor.
Rounding and reporting conventions matter for trend charts. Some files show a measured percentage; others show a threshold statement such as ≥99%. Do not average those styles blindly in a spreadsheet. Note the reporting style next to the lot number so a later reader does not invent false precision or false decline between batches.
Detector saturation and overloaded injections can make a main peak look artificially dominant. You will not always see raw chromatogram files as a buyer, but if a report looks oddly perfect with no minor peaks labeled at all, it is fair to ask whether the method summary and integration rules are available for review.
Practical checks for lab buyers
Compare the product page claim to the COA for your batch. Note units and rounding. Prefer lot-specific PDFs from the COA Library over screenshots of an older lot pasted into a Slack thread. If a blend SKU is on the order, understand whether the file covers the blend or each component — and request clarification when the paperwork is ambiguous.
Counterfeit or mislabeled research chemicals are an industry-wide problem. HPLC on a COA helps, but receiving controls at your institution still matter: visual check of the lyophilized cake or powder, lot match against the packing list, and quarantine until documentation is filed. A high purity claim on a marketing page is not a substitute for that intake habit.
For recurring SKUs such as NAD+, GHK-Cu, or MOTS-c, keep a simple lot ledger: date received, lot ID, reported HPLC value, identity method, and storage location. When a control drifts, that ledger is faster than reconstructing history from email attachments.
- Match vial lot to the COA header before opening the chromatogram discussion
- Copy the reported purity string exactly (including ≥) into the notebook
- Note detection wavelength or method ID when the file provides it
- Flag blends and multi-component SKUs for separate identity questions
- Escalate missing lots to orders@nextdaypeptides.com with order number and label photos
How catalog claims relate to lot data
Product pages identify the compound and point buyers to lot documentation. They are not living dashboards of every vial in inventory and they are not a catalog-wide HPLC guarantee. Manufacturing and testing move in batches; the COA is the measured instance. Buyers who treat a storefront slogan as a certificate for an unopened box are skipping a step that most institutional SOPs already require.
When a lot posts a measured purity slightly different from a sibling lot, that is expected analytical and process variation, not automatically a quality failure. Investigate when the method, identity, or lot linkage is wrong, not when two certificates show different digits after the decimal on different days.
If your institution requires a stated purity minimum, write that requirement against the lot file before checkout. We cannot invent a higher bar after the fact by reinterpreting an old PDF. Procurement notes in the order or a prior email trail save everyone a week of back-and-forth.
Browse the products catalog for presentation and identity first, then confirm the lot file after delivery. Selection and verification are sequential jobs; collapsing them into “the website said 99%” is how receiving discipline erodes.
Comparing lots without false precision
Side-by-side lot comparison is useful when a protocol is picky. It is less useful when people treat every 0.1% swing as a scientific event. Focus first on whether identity still matches, whether appearance and fill look consistent with prior receipts, and whether storage history after delivery could explain a performance change better than the purity line.
If you retain sealed retain vials, keep them under the same storage SOP as working stock. Comparing a carefully frozen retain to a working vial that spent a long weekend on a warm bench is not an HPLC story — it is a handling story. Pair purity paperwork with the receiving notes described in our lyophilized storage article when you troubleshoot.
For multi-site labs, standardize who files the COA and who is allowed to open a new lot into a shared study. Split ownership is how one site runs on lot A documentation while another site has already moved to lot B without updating the shared binder.
When you do need a formal lot bridge study, define acceptance criteria up front: identity match required, purity within a stated band, and assay performance within historical controls. Post-hoc storytelling about percentages rarely satisfies a methods review.
Thinking about impurities without panic
A non-100% result means other integrated signal exists under the method's rules. Those species may be process-related peptide variants, unrelated absorbances, or integration artifacts depending on the chromatogram. Panic ordering a “cleaner” vial from a random marketplace rarely beats asking for the correct lot file and reading the identity section.
Research workflows differ in how much impurity profile they can tolerate. An analytical standard workflow may care more than a rough screening plate. Put the sensitivity of your assay in the purchasing requirement instead of assuming every peer lab needs the same paperwork depth. RUO supply is about intended use context; it is not a promise that one purity number fits every experimental design.
Do not translate impurity area into a clinical risk narrative. These materials are Research Use Only. Impurity discussion here is about experimental confounders and documentation quality for laboratory work, not about safety for human or animal administration — which is outside the scope of this catalog entirely. See the RUO article for how we frame that boundary in plain language.
When orthogonal checks earn their keep
HPLC area percent is one lens. Mass spectrometry, amino-acid analysis, residual-solvent panels, and in-house assay controls are other lenses. Orthogonal data becomes valuable when your method is impurity-sensitive, when a new supplier relationship starts, or when a control failure coincides with a lot change.
You do not need every orthogonal test on every order. Over-testing burns budget; under-testing burns weeks. Map test depth to assay risk: screening work may lean on catalog claims plus lot HPLC/identity; quantitative work may justify retain testing or second-method confirmation.
Document why you chose a given depth. Future staff should see “we require MS identity for this assay class” as a written norm, not as tribal knowledge that vanishes when a technician graduates.
How to brief colleagues and vendors
When you ask a supplier about purity, name the lot, the product SKU, and the field you are questioning. Vague messages like “is this really 99%?” produce vague answers. Specific messages like “lot X COA shows Y% by HPLC method Z — please confirm which file applies to the vials shipping on order N” get actionable replies.
Inside the lab, avoid shorthand that collapses identity and purity into “it's good.” Train new technicians to say “HPLC as reported on lot … with MS identity listed” when they hand off a vial. That habit prevents folklore from replacing paperwork when staff turn over.
If you publish or present methods, cite the lot and the reported purity string rather than the storefront slogan alone. Reviewers and future you will thank you when the catalog title has shifted or a synonym page has been consolidated.
RUO framing and what this metric is not
Purity language on this site describes research materials. It is not a potency claim for human use, not a bioavailability statement, not a therapeutic assurance, and not an invitation to self-experiment. High HPLC purity does not make a peptide appropriate for injection, ingestion, or any non-laboratory use.
Educational copy in this hub stays on procurement and documentation topics: reading claims, matching lots, and understanding analytical limits. We do not provide dosage, cycles, or clinical outcome guidance. If a sentence on a third-party site mixes purity marketing with personal-use instructions, that is not how Nextday Peptides writes product or article copy.
Questions about an order, a missing COA, or a damaged shipment belong with orders@nextdaypeptides.com and our shipping policy. Questions about whether a compound is legal or appropriate for a non-research purpose are outside what a purity article can answer — and outside what RUO supply is for.
Bottom line
Treat an HPLC percentage on a lot COA as a useful, method-bound quality signal for that lot — then verify it on the vial you actually received, beside an identity method, with receiving discipline that survives staff turnover. That is the whole game for most lab buyers.
Use the catalog for selection, the COA for the batch, and institutional SOPs for everything that happens after the vial enters your cold storage. Purity percentages help you compare materials; they do not replace experimental controls, and they do not change the Research Use Only boundary on these products.
When purity conversations get heated in a lab meeting, return to the operational checklist: lot match, method context, identity present, storage history known. Those four anchors usually restore clarity faster than arguing about a tenth of a percent.
Keep expectations calibrated for colleagues outside analytical chemistry. A short explanation that area percent is method-bound prevents product-page slogans from becoming mythology in grant drafts and vendor scorecards.